Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?

Literature DB >> 19424471

Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?

Lynn Stothers¹.

Abstract

Entities: Species

Year: 2009 PMID： 19424471 PMCID： PMC2666898 DOI： 10.5489/cuaj.1049

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

× No keyword cloud information.

28 in total

Review 1. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.

Authors: Roberto Antonicelli; Fabiola Olivieri; Valeria Morichi; Elisa Urbani; Valerio Mais
Journal: Int J Cardiol Date: 2008-07-09 Impact factor: 4.164

Review 2. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Authors: Marianne Canonico; Geneviève Plu-Bureau; Gordon D O Lowe; Pierre-Yves Scarabin
Journal: BMJ Date: 2008-05-20

Review 3. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.

Authors: C Perrotta; M Aznar; R Mejia; X Albert; C W Ng
Journal: Cochrane Database Syst Rev Date: 2008-04-16

4. The effect of low-dose estrogen therapy on ovariectomized female rabbit bladder.

Authors: Yung-Shun Juan; Anita Mannikarottu; Barry A Kogan; Robert E Leggett; Catherine Whitbeck; Paul Chichester; Wei-Yu Lin; Arnold Johnson; Robert M Levin
Journal: Urology Date: 2008-03-04 Impact factor: 2.649

Review 5. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart.

Authors: Howard N Hodis
Journal: Cleve Clin J Med Date: 2008-05 Impact factor: 2.321

6. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Authors: Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; Joann E Manson; Robert D Langer; Mary Pettinger; Susan L Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary Jo O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Journal: Am J Epidemiol Date: 2008-04-29 Impact factor: 4.897

Review 1. Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report.

Authors: Gernot Bonkat; Tommaso Cai; Carlotta Galeone; Bela Koves; Franck Bruyere
Journal: Eur Urol Open Sci Date: 2022-08-23

1 in total

Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?

Review 1. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.

Review 2. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Review 3. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.

4. The effect of low-dose estrogen therapy on ovariectomized female rabbit bladder.

Review 5. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart.

6. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

7. The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats.

8. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.

Review 9. Oestrogens for urinary incontinence in women.

Review 10. Transdermal hormone therapy and bone health.

Review 1. Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report.